Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000559894 | SCV000626513 | likely benign | Glycogen storage disease, type II | 2024-12-22 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000780266 | SCV000917382 | uncertain significance | not specified | 2017-09-25 | criteria provided, single submitter | clinical testing | Variant summary: c.1437+8G>A gene is an intronic change that involves a non-conserved nucleotide. 4/5 programs in Alamut indicate this variant to not affect a normal splicing pattern, however no functional studies supporting these predictions were published at the time of evaluation. The variant is present in the control population datasets of ExAC and gnomAD at frequency of 0.00011 (12/ 116298 and 29/ 243980 chrs tested, respectively), predominantly in individuals of South Asian descent (0.0008774; 10/16372 and 27/30772, chrs respectively, including 1 homozygote occurrence). The observed individual frequencies do not exceed the maximum expected allele frequency for a pathogenic variant of 0.004. The variant of interest has not, to our knowledge, been cited by published reports or reputable databases/clinical laboratories. Taken together, the variant was classified as VUS-Possibly Benign until more data become available. |
Prevention |
RCV003900114 | SCV004715992 | likely benign | GAA-related disorder | 2020-08-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |